129.7
[1]. Furugohri T, et al. DU-17b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost. 2008 Sep;(9):152-9.
[2]. Mendell J, Lee F, Chen S, The Effects of the Antiplatelet Agents, Aspirin and Naproxen, on Pharmacokinetics and Pharmacodynamics of the Anticoagulant Edoxaban, a Direct Factor Xa Inhibitor. J Cardiovasc Pharmacol. 201 Apr 2.
H02-H15-H19-H5
P21-P2-P270-P271-P280-P02+P52-P0+P0-P0-P2+P-P05-P501